Evidence map›Paper›PMID 30833714›Full record

ArticleScientific reports2019

The Impact of Varying Cooling and Thawing Rates on the Quality of Cryopreserved Human Peripheral Blood T Cells.

Jasmin Baboo, Peter Kilbride, Mike Delahaye, Stuart Milne, Fernanda Fonseca, Magdalena Blanco, Julie Meneghel, Alex Nancekievill, Nick Gaddum, G John Morris

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Advancing CAR-T cell therapy: Insights into patient biology, leukapheresis, and cryopreservation.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modeling immune checkpoint inhibitor associated myocarditisJournal of molecular and cellular cardiology plus · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Conduction-Dominated Cryomesh for Organism Vitrification.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  16. Review
  17. Article
  18. Research progress on optimization ofFrontiers in bioengineering and biotechnology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Jasmin BabooCell and Gene Therapy Catapult, 12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
Peter KilbrideAsymptote, General Electric Healthcare, Sovereign House, Histon, Cambridge, CB24 9BZ, UK.
Mike DelahayeCell and Gene Therapy Catapult, 12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
Stuart MilneAsymptote, General Electric Healthcare, Sovereign House, Histon, Cambridge, CB24 9BZ, UK.
Fernanda FonsecaUMR GMPA, AgroParisTech, INRA, Université Paris Saclay, 78850, Thiverval-Grignon, France.ORCID 0000-0003-3394-182X
Magdalena BlancoCell and Gene Therapy Catapult, 12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
Julie MeneghelAsymptote, General Electric Healthcare, Sovereign House, Histon, Cambridge, CB24 9BZ, UK.
Alex NancekievillAsymptote, General Electric Healthcare, Sovereign House, Histon, Cambridge, CB24 9BZ, UK.
Nick GaddumCell and Gene Therapy Catapult, 12th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
G John MorrisAsymptote, General Electric Healthcare, Sovereign House, Histon, Cambridge, CB24 9BZ, UK. GJohn.Morris@ge.com.
Asymptote (United Kingdom) · GBCell Therapy Catapult · GBAgroParisTech · FRGeneral Electric (Spain) · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the clinical delivery of immunotherapies it is anticipated that cells will be cryopreserved and shipped to the patient where they will be thawed and administered. An established view in cellular cryopreservation is that following freezing, cells must be warmed rapidly (≤5 minutes) in order to maintain high viability. In this study we examine the interaction between the rate of cooling and rate of warming on the viability, and function of T cells formulated in a conventional DMSO based cryoprotectant and processed in conventional cryovials. The data obtained show that provided the cooling rate is -1 °C min

Indexed as

Cell SurvivalCold TemperatureCryopreservationFreezingHumansT-Lymphocytes

Identifiers

PMID30833714
PMCPMC6399228
OpenAlexW2918637572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.